- Home
- GPRK vs XOMA Comparison
GPRK vs XOMA Comparison
Compare GPRK & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- XOMA
- Stock Information
- Founded
- GPRK 2002
- XOMA 1981
- Country
- GPRK Colombia
- XOMA United States
- Employees
- GPRK N/A
- XOMA N/A
- Industry
- GPRK Oil & Gas Production
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- XOMA Health Care
- Exchange
- GPRK Nasdaq
- XOMA Nasdaq
- Market Cap
- GPRK 335.7M
- XOMA 330.2M
- IPO Year
- GPRK N/A
- XOMA N/A
- Fundamental
- Price
- GPRK $6.60
- XOMA $32.47
- Analyst Decision
- GPRK Buy
- XOMA Strong Buy
- Analyst Count
- GPRK 1
- XOMA 2
- Target Price
- GPRK $11.00
- XOMA $69.50
- AVG Volume (30 Days)
- GPRK 689.9K
- XOMA 57.0K
- Earning Date
- GPRK 08-05-2025
- XOMA 08-13-2025
- Dividend Yield
- GPRK 8.91%
- XOMA N/A
- EPS Growth
- GPRK N/A
- XOMA N/A
- EPS
- GPRK 0.81
- XOMA N/A
- Revenue
- GPRK $560,354,000.00
- XOMA $44,952,000.00
- Revenue This Year
- GPRK N/A
- XOMA $82.30
- Revenue Next Year
- GPRK N/A
- XOMA $12.59
- P/E Ratio
- GPRK $8.19
- XOMA N/A
- Revenue Growth
- GPRK N/A
- XOMA 194.98
- 52 Week Low
- GPRK $5.66
- XOMA $18.35
- 52 Week High
- GPRK $11.72
- XOMA $35.23
- Technical
- Relative Strength Index (RSI)
- GPRK 50.84
- XOMA 61.79
- Support Level
- GPRK $6.28
- XOMA $32.60
- Resistance Level
- GPRK $6.67
- XOMA $34.60
- Average True Range (ATR)
- GPRK 0.20
- XOMA 1.82
- MACD
- GPRK 0.02
- XOMA 0.09
- Stochastic Oscillator
- GPRK 63.01
- XOMA 66.75
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.